“And Then COVID Hits”: A Qualitative Study of How Jails Adapted Services to Treat Opioid Use Disorder During COVID-19

Harrington, Calla; Bailey, Amelia; Delorme, Elizabeth; Hano, Samantha; Evans, Elizabeth

doi:10.1080/10826084.2022.2155480

Cited by 8 publications

(3 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Opioid use disorder screening and assessment processes were mostly comparable by site, with some variation that may have impacted who was identified as having OUD. As detailed elsewhere, 15 COVID-19 occurred during the implementation of the MOUD program in these jails and staff adapted programming to ensure access to MOUD. More research is needed to examine the impact of COVID-19 on use of MOUD in carceral settings and related outcomes.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Correlates and Patterns in Use of Medications to Treat Opioid Use Disorder in Jail

2023

Self Cite

View full text Add to dashboard Cite

Objectives: Little is known about the correlates of use of medications to treat opioid use disorder (MOUD, ie, buprenorphine, methadone, naltrexone) offered in jails. We evaluated the implementation and outcomes of a MOUD program offered by 2 of the first jails nationwide to provide access to such care. Methods: We examined use of MOUD among adults with opioid use disorder (n = 347) incarcerated by 2 rural jails in Massachusetts (2018Massachusetts ( -2021. We examined MOUD transitions from intake to during incarceration. Using logistic regression, we examined factors associated with in-jail use of MOUD. Results: At jail entry, 48.7% of individuals with opioid use disorder were being treated with MOUD. During incarceration, 65.1% received MOUD, attributable to a 9.2% increase in use of methadone (from 15.9% to 25.1%) and a 10.1% increase in use of buprenorphine (from 28.5% to 38.6%). During incarceration, 32.3% of individuals were continued on the same MOUD from the community, 25.4% were started, 8.9% stopped, and 7.5% switched type. A total of 25.9% entered jail not on any MOUD and were not started on it. Use of MOUD during incarceration was positively associated with having received MOUD in the community (odds ratio, 12.2; 95% confidence interval, 5.8-25.5) and incarceration at site 1 compared with site 2 (OR, 24.6; 95% CI, 10.9-54.4). Conclusions: Expanded access to MOUD in jails can engage an at-risk population with treatment. Understanding factors related to this population's use of MOUD may aid efforts to optimize care during incarceration and after community re-entry.

show abstract

Section: Discussionmentioning

confidence: 99%

“…12 Importantly, jails may provide critical access to MOUD in rural areas and other communities where availability and access are limited. 13 However, with some exceptions (eg, Donelan et al 14 and Harrington et al 15 ), the ability of rural jails to provide access to MOUD has not been examined.…”

mentioning

confidence: 99%

Correlates and Patterns in Use of Medications to Treat Opioid Use Disorder in Jail

2023

Self Cite

View full text Add to dashboard Cite

show abstract

“…In the community, treatment centers across the United States adjusted to decreased in-person care ( Alexander et al, 2020 ), including increasing telehealth and buprenorphine take-home doses per the new SAMHSA guidelines ( SAMHSA, 2020 ). However, we know little regarding how COVID-19 has impacted MOUD utilization in correctional facilities or clinical outcomes after release from incarceration (however see Harrington et al, 2023 ; Mukherjee & El-Bassel, 2020 ). The current study aimed to longitudinally assess the statewide implementation of MOUD in Vermont's correctional system and the subsequent impact of COVID-19 on MOUD engagement among individuals incarcerated in Vermont as well as continuation of MOUD and the prevalence of overdose following release from incarceration.…”

Section: Introductionmentioning

confidence: 99%

The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose

Klemperer,

Wreschnig,

Crocker

et al. 2023

Journal of Substance Use and Addiction Treatment

Self Cite

View full text Add to dashboard Cite

Patient and provider experiences with opioid use disorder care delivered via telehealth: A systematic mixed-studies review

Aronowitz,

Zucker,

Thompson

et al. 2025

Drug and Alcohol Dependence

View full text Add to dashboard Cite

“And Then COVID Hits”: A Qualitative Study of How Jails Adapted Services to Treat Opioid Use Disorder During COVID-19

Cited by 8 publications

References 23 publications

Correlates and Patterns in Use of Medications to Treat Opioid Use Disorder in Jail

Correlates and Patterns in Use of Medications to Treat Opioid Use Disorder in Jail

The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose

Patient and provider experiences with opioid use disorder care delivered via telehealth: A systematic mixed-studies review

Contact Info

Product

Resources

About